Search

Author/Creator Eigl, Bernhard J

2. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Issue 10064 (7th January 2017)

Authors:
Balar, Arjun V; Galsky, Matthew D; Rosenberg, Jonathan E; Powles, Thomas; Petrylak, Daniel P; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A; van der Heijden, Michiel S; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M; Joseph,...
Journal:
Lancet
Issue:
Volume 389:Issue 10064(2017)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Issue 12 (December 2022)

Authors:
Bénard, François; Harsini, Sara; Wilson, Don; Zukotynski, Katherine; Abikhzer, Gad; Turcotte, Eric; Cossette, Mariève; Metser, Ur; Romsa, Jonathan; Martin, Montgomery; Mar, Colin; Saad, Fred; Soucy, Jean-Paul; Eigl, Bernhard J; Black, Peter; Krauze, Andra; Burrell, Steven; Nichol, Alan; Tardif, J...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 12(2022)
Page Start:
1499
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial. Issue 12 (December 2019)

Authors:
Khalaf, Daniel J; Annala, Matti; Taavitsainen, Sinja; Finch, Daygen L; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Sunderland, Katherine; Azad, Arun A; Kollmannsberger, Christian K; Eigl, Bernhard J; Noonan, Krista; Wadhwa, Deepa; Attwell, Andrew; Keith, Bruce; Ellard, Susan L; Le, Lyly; G...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1730
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗